CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice.
Narcolepsy with cataplexy is a rare and severe sleep disorder caused by the destruction of orexinergic neurons in the lateral hypothalamus. The genetic and environmental factors associated with narcolepsy, together with serologic data, collectively point to an autoimmune origin. The current animal models of narcolepsy, based on either disruption of the orexinergic neurotransmission or neurons, do not allow study of the potential autoimmune etiology. Here, we sought to generate a mouse model that allows deciphering of the immune mechanisms leading to orexin(+) neuron loss and narcolepsy development. We generated mice expressing the hemagglutinin (HA) as a "neo-self-antigen" specifically in hypothalamic orexin(+) neurons (called Orex-HA), which were transferred with effector neo-self-antigen-specific T cells to assess whether an autoimmune process could be at play in narcolepsy. Given the tight association of narcolepsy with the human leukocyte antigen (HLA) HLA-DQB1*06:02 allele, we first tested the pathogenic contribution of CD4 Th1 cells. Although these T cells readily infiltrated the hypothalamus and triggered local inflammation, they did not elicit the loss of orexin(+) neurons or clinical manifestations of narcolepsy. In contrast, the transfer of cytotoxic CD8 T cells (CTLs) led to both T-cell infiltration and specific destruction of orexin(+) neurons. This phenotype was further aggravated upon repeated injections of CTLs. In situ, CTLs interacted directly with MHC class I-expressing orexin(+) neurons, resulting in cytolytic granule polarization toward neurons. Finally, drastic neuronal loss caused manifestations mimicking human narcolepsy, such as cataplexy and sleep attacks. This work demonstrates the potential role of CTLs as final effectors of the immunopathological process in narcolepsy.
Center for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France;
Raphaël
R
Bernard-Valnet
Center for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France;
Lidia
L
Yshii
Center for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France;
Clémence
C
Quériault
Center for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France;
Xuan-Hung
XH
Nguyen
Center for Research in Neuroscience, INSERM U1028, CNRS UMR 5292, 69675 Bron, France;
Sébastien
S
Arthaud
Center for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France;
Magda
M
Rodrigues
Center for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France;
Astrid
A
Canivet
Center for Research in Neuroscience, INSERM U1028, CNRS UMR 5292, 69675 Bron, France;
Anne-Laure
AL
Morel
Center for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France;
Arthur
A
Matthys
Center for Brain Research, Medical University of Vienna, 1090 Vienna, Austria;
Jan
J
Bauer
Center for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France;
Béatrice
B
Pignolet
National Reference Center for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia, and Kleine-Levin Syndrome, Department of Neurology, Gui-de-Chauliac Hospital, Centre Hospitalo-Universitaire de Montpellier, INSERM U1061, 34295 Montpellier, France;
Yves
Y
Dauvilliers
Center for Research in Neuroscience, INSERM U1028, CNRS UMR 5292, 69675 Bron, France;
Christelle
C
Peyron
Center for Pathophysiology Toulouse Purpan, Université Toulouse III, INSERM U1043, CNRS UMR 5282, 31024 Toulouse, France; Department of Immunology, Toulouse University Hospitals, 31059 Toulouse, France roland.liblau@inserm.fr.
Roland S
RS
Liblau
D000818:Animals; D001323:Autoantibodies / Q000378:metabolism; D001324:Autoantigens / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002450:Cell Communication; D003602:Cytotoxicity, Immunologic; D006388:Hemagglutinins / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D007249:Inflammation / Q000473:pathology; D008264:Macrophages / Q000378:metabolism; D008810:Mice, Inbred C57BL; D009290:Narcolepsy / Q000276:immunology* / Q000473:pathology*; D009474:Neurons / Q000378:metabolism / Q000473:pathology*; D000068797:Orexins / Q000378:metabolism*; D010641:Phenotype; D013602:T-Lymphocytes, Cytotoxic / Q000378:metabolism; D018417:Th1 Cells / Q000378:metabolism
D001323:Autoantibodies; D001324:Autoantigens; D006388:Hemagglutinins; D000068797:Orexins
CD8 T cells; autoimmunity; narcolepsy; orexin; sleep disorders